Hematological Markers as Predictors of Treatment Outcomes with Lu-177 DOTATATE in Patients with Advanced Neuroendocrine Tumors.

Swayamjeet Satapathy,Anish Bhattacharya,Ashwani Sood,Rakesh Kapoor,Rajesh Gupta,Apurva Sood,Prashant Sharma,Divya Khosla,Bhagwant Rai Mittal

Hematological Markers as Predictors of Treatment Outcomes with Lu-177 DOTATATE in Patients with Advanced Neuroendocrine Tumors.

2021

Swayamjeet Satapathy
Anish Bhattacharya
Ashwani Sood
Rakesh Kapoor
Rajesh Gupta
Apurva Sood
Prashant Sharma
Divya Khosla
Bhagwant Rai Mittal

Background: Chronic inflammation has been linked to the development and prognosis of neuroendocrine tumors (NETs). The current study intended to evaluate the role of peripheral hematological inflam...

Keywords:

in patient
Medicine
Peripheral
Internal medicine
platelet lymphocyte ratio
177Lu-DOTATATE
Neuroendocrine tumors
Oncology
Inflammation
treatment outcome

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations